Pine Labs Ltd
Pine Labs Ltd (PINELABS) last reported results for the quarter ended Jun 2026, with sales of ₹737 crore and net profit of ₹20 crore. The stock last traded at ₹173, a market capitalisation of ₹19,942 crore, on a P/E of 154. Over the past 52 weeks the stock has ranged between ₹135 and ₹284. Figures are as of 6 Oct 2026 and are not real time.
Pine Labs Ltd share price and key metrics
- Current price
- ₹173
- Market cap
- ₹19,942 cr
- Stock P/E
- 154
- Book value
- ₹51.3
- ROE
- 2.46%
- ROCE
- 4.15%
- Dividend yield
- 0.00%
- 52w high / low
- 284/135
Metrics as of 6 Oct 2026. Not real time.
Track Pine Labs Ltd
Cruxal reads every Pine Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Pine Labs Ltd growth and returns
- 10 Years
- %
- 5 Years
- 32%
- 3 Years
- 19%
- TTM
- 20%
- 10 Years
- %
- 5 Years
- 32%
- 3 Years
- 36%
- TTM
- 262%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- -4%
- 3 Years
- -3%
- Last Year
- 2%
Pine Labs Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹737 cr, up 19.6% from ₹616 cr a year earlier. Net profit was ₹20 cr, up 300.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 552 | 602 | 599 | 616 | 650 | 744 | 701 | 737 |
| Expenses | 519 | 525 | 542 | 571 | 575 | 612 | 594 | 642 |
| Operating profit | 32 | 77 | 57 | 45 | 75 | 132 | 106 | 95 |
| OPM % | 6% | 13% | 9% | 7% | 12% | 18% | 15% | 13% |
| Other income | 22 | -30 | 12 | 37 | 23 | 23 | 50 | 29 |
| Interest | 18 | 22 | 22 | 21 | 21 | 24 | 17 | 13 |
| Depreciation | 75 | 76 | 69 | 65 | 66 | 68 | 71 | 73 |
| Profit before tax | -38 | -51 | -22 | -5 | 11 | 63 | 68 | 38 |
| Tax % | -16% | 11% | 30% | -199% | 47% | 32% | 13% | 48% |
| Net profit | -32 | -57 | -29 | 5 | 6 | 42 | 59 | 20 |
| EPS (₹) | -0.38 | -0.67 | -0.34 | 0.11 | 0.13 | 0.37 | 0.52 | 0.17 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Pine Labs Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 848 | 670 | 932 | 1,598 | 1,770 | 2,274 | 2,711 | 2,832 |
| Operating profit | 87 | 110 | 112 | 5 | -25 | 218 | 358 | 409 |
| OPM % | 10% | 16% | 12% | 0.3% | -1.4% | 10% | 13% | 14% |
| Net profit | -47 | -56 | -23 | -265 | -342 | -145 | 113 | 127 |
| EPS (₹) | -3.95 | -4.34 | -1.67 | -18.99 | -4.07 | -1.73 | 0.98 | 1.19 |
TTM is the trailing twelve months to the most recent quarter.
Pine Labs Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 12 | 13 | 14 | 0.02 | 0.10 | 0.10 | 115 |
| Reserves | 1,035 | 1,178 | 1,900 | 3,664 | 3,466 | 3,431 | 5,781 |
| Borrowings | 176 | 191 | 236 | 514 | 730 | 1,046 | 441 |
| Other liabilities | 2,225 | 3,185 | 4,111 | 5,141 | 5,422 | 6,222 | 6,952 |
| Total liabilities | 3,448 | 4,567 | 6,260 | 9,318 | 9,618 | 10,698 | 13,288 |
| Fixed assets | 1,017 | 980 | 1,019 | 2,103 | 1,920 | 1,825 | 1,856 |
| CWIP | 52 | 48 | 122 | 269 | 222 | 160 | 148 |
| Investments | 40 | 34 | 50 | 18 | 21 | 30 | 28 |
| Other assets | 2,338 | 3,505 | 5,070 | 6,928 | 7,455 | 8,683 | 11,256 |
| Total assets | 3,448 | 4,567 | 6,260 | 9,318 | 9,618 | 10,698 | 13,288 |
As reported by the company. Total assets equal total liabilities by construction.
Pine Labs Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 11 | 111 | -79 | -152 | -229 | 50 | 395 |
| Cash from investing | 112 | -260 | -443 | -441 | -22 | -159 | -1,339 |
| Cash from financing | 1,431 | 823 | 1,644 | 2 | -220 | -201 | 1,972 |
| Net cash flow | 1,554 | 674 | 1,122 | -591 | -471 | -310 | 1,029 |
| Free cash flow | -156 | -54 | -407 | -517 | -486 | -99 | 161 |
| CFO / operating profit | 86% | 114% | -25% | -1,258% | 872% | 5% | 112% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Pine Labs Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | -4% | -3% | -7% | -8% | -0% | 4% |
| Debtor days | 92 | 196 | 116 | 135 | 134 | 136 | 140 |
| Inventory days | 5 | 23 | — | 134 | 65 | 38 | 32 |
| Days payable | 144 | 1,345 | — | 1,233 | 908 | 693 | 382 |
| Cash conversion cycle | -47 | -1,126 | 116 | -964 | -708 | -519 | -210 |
| Working capital days | -722 | -1,252 | -1,255 | -813 | -807 | -762 | -609 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Pine Labs Ltd shareholding pattern
| % held | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| FIIs | 5.23% | 4.80% | 9.49% |
| DIIs | 11.26% | 11.81% | 24.82% |
| Public | 83.51% | 83.39% | 65.68% |
| No. of shareholders | 1,27,792 | 1,17,551 | 1,78,120 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Pine Labs Ltd corporate filings
- Pine Labs Ltd files routine regulatory disclosure under Regulation 30Company Updatelow impact
Cruxal's analysis: Pine Labs Ltd has submitted a press release/media release under Regulation 30 of the SEBI…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: As per the enclosed file.
Read the full analysis - Pine Labs Ltd files routine regulatory disclosure under Regulation 30Company Updatelow impact
Cruxal's analysis: Pine Labs Ltd has submitted a routine press release filing under Regulation 30 of the…
Read the full analysis - Pine Labs Ltd files routine regulatory disclosure under Regulation 30Company Updatelow impact
Cruxal's analysis: The company has submitted a press release/media release under Regulation 30 of the SEBI…
Read the full analysis - Pine Labs Ltd announces routine allotment of equity shares under ESOP schemeCompany Updatelow impact
Cruxal's analysis: Pine Labs Ltd has filed a disclosure regarding the allotment of equity shares pursuant to…
Read the full analysis - Pine Labs Limited Announces Successful Conclusion of 28th AGM with Shareholder Approval for Financial Statements and Director Remuneration RevisionsAGM/EGMlow impact
Cruxal's analysis: Pine Labs Limited has successfully concluded its 28th Annual General Meeting held on…
Read the full analysis - Pine Labs Limited concludes 28th Annual General Meeting; focuses on routine governance and remuneration revisionsAGM/EGMlow impact
Cruxal's analysis: Pine Labs Limited has successfully concluded its 28th Annual General Meeting held on…
Read the full analysis - Pine Labs Ltd files routine media release under Regulation 30Company Updatelow impact
Cruxal's analysis: Pine Labs Ltd has submitted a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Pine Labs Ltd issues communication regarding Annual Report for FY 2025-26Company Updatelow impact
Cruxal's analysis: The company has issued a formal communication to shareholders providing the weblink to…
Read the full analysis - Pine Labs Ltd files Annual Report for the financial year 2025-26Otherslow impact
Cruxal's analysis: Pine Labs Ltd has submitted its Annual Report for the financial year 2025-26 as per…
Read the full analysis - Pine Labs Ltd: Routine Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: The company has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - Pine Labs Ltd files Annual Report for FY 2025-26Company Updatelow impact
Cruxal's analysis: Pine Labs Ltd has submitted its Annual Report pursuant to Regulation 34(1) of the SEBI…
Read the full analysis - Pine Labs Limited Announces Notice of 28th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Pine Labs Limited has issued a notice for its 28th Annual General Meeting (AGM) scheduled…
Read the full analysis - Pine Labs Ltd: Routine Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: The company has published its financial results in newspapers as per Regulation 30 of the…
Read the full analysis - Pine Labs Ltd announces 28th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Pine Labs Ltd has issued an intimation regarding its 28th Annual General Meeting. The…
Read the full analysis - Pine Labs Ltd announces grant of Employee Stock Options (ESOPs)Company Updatelow impact
Cruxal's analysis: Pine Labs Ltd has issued a regulatory disclosure regarding the grant of Employee Stock…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.